Allarity Therapeutics, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Allarity Therapeutics, Inc. (ALLR) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$5.56 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-30
- Allarity Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$5.56M.
- Allarity Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$8.52M.
- Allarity Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$5.58M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$5.56M 10-K · filed 2026-03-30 |
| 2024-12-31 | -$8.52M 10-K · filed 2026-03-30 |
| 2023-12-31 | -$5.58M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |